Govt extends HLL Lifecare bid submission deadline till February 28

In view of the prevailing situation arising out of the COVID-19 pandemic and on the request of the interested bidders, the late date for submission of EoIs is extended to February 28, DIPAM said in a notice on its website.

Also Read:MSN to launch generic anti-COVID pill Molnupiravir

The due date for intimation to the qualified interested bidders (QIBs) by the DIPAM has also been extended by a month till March 14.

HLL, a CPSE under the Ministry of Health and Family Welfare, is involved in manufacturing and marketing a range of contraceptives, women's healthcare products, hospital supplies as well as other pharmaceutical products.

HLL is also engaged in providing healthcare and diagnostic services, consultancy and contract services for healthcare infrastructure projects and consultancy services for procurement of medical equipment and devices in the healthcare sector and caters to both domestic and international markets.

As of March 31, 2021, HLL's authorised capital was Rs 300 crore and its paid-up share capital was Rs 15.53 crore.

With this deadline extension, the strategic sale of HLL Lifecare is now expected to spill over to the next financial year beginning April 1.

Also Read:Pfizer oral COVID pill Paxlovid approved in Canada